Association between statin usage and mortality outcomes in aging U.S. cancer survivors: a nationwide cohort study
Our study reveals that the use of lipophilic statins is significantly associated with lower all-cause and cancer-cause mortality risks among aging cancer survivors.
Authors
- Liting Zhou (ORCID: https://orcid.org/0000-0003-1852-4745)
- Weiwen Jiang (ORCID: https://orcid.org/0000-0002-9004-487X)
- Pan Lai
- Yi‐Jun Ge
- Yanrong Ye (ORCID: https://orcid.org/0000-0002-8189-1292)
- Feng‐Ling Yang (ORCID: https://orcid.org/0000-0003-2392-8381)
- Shaozhuang Chen
- Shan Ding
- Jiaqi Zhang (ORCID: https://orcid.org/0000-0002-7449-4176)
- Minze Chen
Institutions
- Fujian Medical University (CN)
- Sun Yat-sen University (CN)
- Longyan University (CN)
- Peking University (CN)
- Fudan University (CN)
- Auckland University of Technology (NZ)
- First Affiliated Hospital of Fujian Medical University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Aging Clinical and Experimental Research
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1007/s40520-024-02851-2
- Citations
- 2
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.57